Geriatric Pharmacokinetics

Age-related gastrointestinal changes can modify how much and how quickly a medicine reaches the circulation. Changes in body composition then influence distribution, meaning the movement of drug through body tissues, and can alter concentrations and exposure. Considering absorption and distribution together helps clinicians interpret unexpectedly strong, weak, delayed, or prolonged drug effects in older adults.

Changes in hepatic blood flow can affect metabolism, while altered renal clearance can change how efficiently medicines are removed. These processes influence drug concentrations, exposure, and half-life, the time course over which drug levels decline. Recognizing their combined effect is important when a regimen appears to produce accumulation or prolonged effects.

Multiple medications can complicate interpretation of a drug response because their combined effects may alter pharmacokinetic behavior or increase clinical risk. In older adults, this concern is especially important when altered absorption, distribution, metabolism, or excretion already changes exposure. Reviewing the full medication regimen helps clinicians recognize possible interactions, accumulation, and toxicity.

Individualized dosing translates pharmacokinetic assessment into a patient-specific treatment plan. Clinicians consider how age-related changes may affect concentrations, half-life, and exposure, then use therapeutic monitoring when appropriate to evaluate the response. This approach supports adjustment toward effective therapy while reducing the likelihood that altered handling will lead to accumulation or toxicity.

Therapeutic monitoring is particularly valuable when observed treatment does not match the intended result. Pharmacokinetic information can help investigate whether altered drug handling contributes to excessive exposure, an adverse drug reaction, or treatment failure. In older patients taking multiple medicines, monitoring adds clinical evidence for deciding whether the regimen remains both effective and safe.

Clinicians apply geriatric pharmacokinetics when age-related changes make a standard medication plan less predictable. The field informs decisions about dosing and follow-up by linking changes in body composition, gastrointestinal function, hepatic blood flow, and renal clearance with drug exposure. Its clinical purpose is to balance therapeutic benefit against older adults’ greater vulnerability to toxicity.